Nyxoah S.A. ( NYXH) - Key Metrics
NYXH Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q2 | $0.13 | -$0.58 | -$0.29 | -$0.31 |
| 2026Q1 | $0.17 | -$0.43 | -$0.50 | -$0.52 |
| 2025Q4 | $0.14 | -$0.59 | -$0.33 | -$0.33 |
| 2025Q3 | $0.05 | -$0.63 | -$0.55 | -$0.55 |
| 2025Q2 | $0.04 | -$0.55 | -$0.45 | -$0.46 |
NYXH Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q2 | 0% | -0.64 |
| 2026Q1 | 0% | -1.71 |
| 2025Q4 | 0% | -1.66 |
| 2025Q3 | 0% | -1.56 |
| 2025Q2 | 0% | -2.88 |
NYXH
Price: $0.95
52 week price:
Earnings Per Share: -2.56 USD
Exchange: NGM
Sector: Healthcare
Industry: Medical Instruments & Supplies
Country: Belgium
Volume: 11600
Market Capitalization: 136.1 million